Previous slide arrow

European Commission approval of KYGEVVI® for TK2d

IMP warmly welcomes the decision by the European Commission to approve KYGEVVI® (doxecitine and doxribtimine) as the first and only treatment for people living with thymidine kinase 2 deficiency (TK2d) in the European Union.

Lady hugging a child

New MELAS Consensus: A Critical Resource for Doctors and Patients Worldwide

A new consensus on MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke‑like episodes) has just been released. The consensus is the result of a ERN EURO-NMD Workshop dedicated to developing a new clinical consensus on MELAS, attended by leading international experts including IMP’s Chair, Paula Morandi who represented the International mito community.

MELAS Consortium

Announcing IMP’s New Scientific and Medical Advisory Committee

IMP is delighted to introduce our new Scientific and Medical Advisory Committee, a group of internationally respected researchers, clinicians and patient experts who will help guide our work and strengthen our impact for the mitochondrial community worldwide.

Photos of SAMAC members

LHON Awareness Day – 19 September 2025

Watch our webinar on nutrition and mitochondrial diseases with a special focus on LHON.

Title slide of a presentation showing the title 'Exploring the Power of Nutrition in Mitochondrial Diseases'
r


Mitochondrial diseases (mito) are a highly complex set of rare genetic disorders. Mito can cause any symptom in any organ at any age. They rob the body’s cells of energy causing debilitating and often life-threatening organ dysfunction.

About
MITO

NEWS

IMP welcomes European Commission approval of KYGEVVI® for TK2d

European Commission approves KYGEVVI® for TK2d IMP warmly welcomes the decision by the European Commission to approve KYGEVVI® (doxecitine and doxribtimine) as […]...

Announcing IMP’s New Scientific and Medical Advisory Committee

Announcing IMP’s New Scientific and Medical Advisory Committee IMP is delighted to introduce our new Scientific and Medical Advisory Committee, a […]...

New MELAS Consensus: A Critical Resource for Doctors and Patients Worldwide

New MELAS Consensus: A Critical Resource for Doctors and Patients Worldwide In November 2025, leading international experts gathered in Pisa, […]...

MitMED – Building a European Centre of Excellence in Mitochondrial Medicine

MitMED – Building a European Centre of Excellence in Mitochondrial Medicine Mitochondria are central regulators of cellular life, integrating metabolism, […]...

Growing Recognition of the Patient Voice in Research

Growing Recognition of the Patient Voice in Research A meaningful shift is taking place in the rare disease research landscape: […]...

Meet
a member

The POLG Foundation

The PolG Foundation is committed to accelerating research efforts to develop effective treatments and, ultimately, a cure for POLG mitochondrial disorders.


Become
a member

Are you thinking of becoming an IMP member?

Patient Stories

Ellie was a fighter from birth. Born in October 2017, a lack of oxygen at birth meant she needed to spend the first week of life in intensive care. This early battle in life would later be a blessing in disguise as it meant she required regular neurological reviews to review how her brain and movement developed. Ellie’s early months were mainly happy. She cried, babbled and smiled like any baby does and loved baths with her big sister, kicking her legs to music and chatting away with her mum and dad.

About
IMP

International Mito Patients is a non-profit network of national patient organisations involved in mito. The national patient organisations support and advocate for patients, fund research, increase awareness and improve education in their country.

By joining forces, IMP represents a large group of patients, creating a stronger voice on an international level.

IMP’s mission is to increase the quality of life for people with mitochondrial disease by facilitating cross-border cooperation and collaboration among national patient organisations.


Stay up
to date

Translate
Scroll to Top